Edition:
India

ASKA Pharmaceutical Co Ltd (4514.T)

4514.T on Tokyo Stock Exchange

1,363JPY
23 May 2018
Change (% chg)

¥5 (+0.37%)
Prev Close
¥1,358
Open
¥1,372
Day's High
¥1,376
Day's Low
¥1,347
Volume
175,200
Avg. Vol
113,413
52-wk High
¥2,264
52-wk Low
¥1,347

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 10,231.00 -22.633
Dec 13,659.00 49.065
Sep 12,241.00 21.289
Jun 12,813.00 37.076
FY 2017 Mar '17 11,052.00 -34.559
Dec 13,159.00 94.296
Sep 12,329.00 26.811
Jun 11,987.00 18.834
FY 2016 Mar '16 9,683.00 -13.575
Dec 12,425.00 24.553
Sep 10,384.00 7.464
Jun 10,723.00 6.713
 
*Note: Units in Millions ofYen
**Note: Units in Yen

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 15.19 30.95 32.75
P/E High - Last 5 Yrs. 58.18 40.70 45.73
P/E Low - Last 5 Yrs. 15.50 23.63 24.23
Beta 0.76 0.89 0.88
Price to Sales (TTM) 1.16 3.94 5.71
Price to Book (MRQ) 1.29 4.81 5.37
Price to Tangible Book (MRQ) 1.52 5.61 6.94
Price to Cash Flow (TTM) 9.73 22.91 23.33
% Owned Institutions -- 1.21 2.16

Dividends

  Company industry sector
Dividend Yield 0.75 1.56 1.50
Dividend Yield - 5 Year Avg 1.17 1.57 1.51
Dividend 5 Year Growth Rate 0.00 4.47 5.32
Payout Ratio(TTM) 11.27 45.35 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 6.89 3.69 9.21
Sales (TTM) vs TTM 1 Yr. Ago 10.96 4.83 5.69
Sales - 5 Yr. Growth Rate 3.61 10.08 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago 96.86 16.38 19.38
EPS (TTM) vs TTM 1 Yr. Ago 231.65 -- --
EPS - 5 Yr. Growth Rate 235.11 9.87 10.77
Capital Spending - 5 Yr. Growth Rate -5.76 15.52 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.62 2.12 2.19
Current Ratio (MRQ) 2.37 2.90 2.98
LT Debt to Equity (MRQ) 5.16 9.88 12.17
Total Debt to Equity (MRQ) 8.56 13.86 16.44
Interest Coverage (TTM) -- 35.89 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 39.49 54.81 54.45
Gross Margin - 5 Yr. Avg. 41.02 52.15 52.21
EBITD Margin (TTM) 9.82 -- --
EBITD - 5 Yr. Avg 7.90 18.57 10.96
Operating Margin (TTM) 7.51 14.36 4.73
Operating Margin - 5 Yr. Avg. 3.41 14.52 6.40
Pre-Tax Margin (TTM) 7.86 14.82 5.57
Pre-Tax Margin - 5 Yr. Avg. 4.17 14.90 6.81
Net Profit Margin (TTM) 7.01 11.07 1.87
Net Profit Margin - 5 Yr. Avg. 2.99 11.20 3.09
Effective Tax Rate (TTM) 10.75 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. 28.25 23.42 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) 57,254,060 938,135,892 847,064,414
Net Income/Employee (TTM) 4,015,081 110,374,948 99,643,698
Receivable Turnover (TTM) 5.15 5.63 5.78
Inventory Turnover (TTM) 2.60 2.59 3.35
Asset Turnover (TTM) 0.79 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 5.51 11.40 10.95
Return on Assets - 5 Yr. Avg. 2.32 12.91 12.32
Return on Investment (TTM) 7.10 14.84 14.38
Return on Investment - 5 Yr. Avg. 2.93 16.88 16.11
Return on Equity (TTM) 8.97 16.34 16.07
Return on Equity - 5 Yr. Avg. 3.67 17.98 17.39
  1 Year 3 Year 5 Year
Sales % 12.29 7.10 3.61
EPS (TTM) % 319.16 80.81 235.11
Dividend % 0.00 0.00 0.00
Note: Units in Millions of US Dollars

Performance for ASKA Pharmaceutical Co Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 11.85 5.65 84 23
13 Week 12.19 6.86 80 35
26 Week 18.71 4.82 81 29
52 Week 4.57 -16.09 54 12
YTD 10.08 -0.92 58 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 27.41%
# of Holders: 58
Total Shares Held: 8,376,763
3 Mo. Net Change: -1,704,879
# New Positions: 4
# Closed Positions: 1
# Increased Positions: 15
# Reduced Positions: 13
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.